Skip to NavigationSkip to content

Pharmafile - Medical Communications News

The FDA is looking into if the diabetes drug metformin has unsafe levels of a cancer-causing chemical.
Sage Therapeutics has announced that its candidate SAGE-217 flopped in Phase 3 trials investigating its efficacy in symptom reduction for major...
Over 140,000 people died from measles last year, with most of them being children under five, according to World Health Organization (WHO) and the US...
Widespread bribery in India’s pharma industry, Purdue Pharma President ignored addiction concerns with OxyContin, and Lynparza scores NICE...
The FDA has approved the first three generic versions of Novartis’ sphingosine 1-phosphate receptor modulator Gilenya (fingolimod) to treat adult...
NDA's Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising...
A person has been diagnosed with the rare viral infection monkeypox in South West England. It is believed they contracted it while staying in...
NHS under threat from US trade deal, AstraZeneca and Novoheart team up to develop human ‘heart-in-a-jar’ and US step up investigation of opiod...
Few in the NHS trust ‘big tech’ companies to handle patient data in a confidential manner, a recent YouGov poll found.
Immupharma has signed a development agreement with Avion Pharmaceuticals to acquire the licensing rights for Lupuzor, a peptide therapeutic and...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches